- Home
- CYCN vs RKDA Comparison
CYCN vs RKDA Comparison
Compare CYCN & RKDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CYCN | RKDA |
|---|---|---|
| Founded | 2018 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6M | 1.1M |
| IPO Year | 2019 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CYCN | RKDA |
|---|---|---|
| Price | $3.36 | $0.43 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 90.6K | ★ 144.8K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 8.26 | ★ 66.92 |
| EPS | ★ N/A | N/A |
| Revenue | $2,074,000.00 | ★ $4,858,000.00 |
| Revenue This Year | N/A | $61.67 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.70 | N/A |
| 52 Week Low | $1.03 | $0.38 |
| 52 Week High | $8.48 | $6.71 |
Technical Indicators
Market Signals| Indicator | CYCN | RKDA |
|---|---|---|
| Relative Strength Index (RSI) | 41.06 | 37.02 |
| Support Level | $3.04 | $0.38 |
| Resistance Level | $3.42 | $0.55 |
| Average True Range (ATR) | 0.49 | 0.04 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 23.67 | 11.75 |
Price Performance
Historical ComparisonAbout CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.
About RKDA Arcadia Biosciences Inc.
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.